The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes
Authors:
- Stéphanie ThibaultSTStéphanie Thibault
- Anne-Marie LaporteALAnne-Marie Laporte
- Lucimey LimaLLLucimey Lima
- Michel HamonMHMichel Hamon
- 1 January 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 288 (2) , 173-186
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Molecular biology of 5-HT receptorsNeuropharmacology, 1994
- Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agentsTrends in Pharmacological Sciences, 1993
- WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptorsEuropean Journal of Pharmacology, 1993
- S 14506: A novel, potent, high‐efficacy 5‐HT1A agonist and potential anxiolytic agentDrug Development Research, 1992
- Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptideNeuroscience Letters, 1990
- Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteinsBiochemical Pharmacology, 1990
- The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptorNature, 1988
- The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino) chromanEuropean Journal of Pharmacology, 1987
- 3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolyticNaunyn-Schmiedeberg's Archives of Pharmacology, 1985
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973